In neuroblastoma cells in which the oncogene MYCN is amplified, eEF2K is also activated and is required for these cells to survive nutrient withdrawal, as shown by the observation that they are very sensitive to the eEF2K inhibitor A-484954 [49]. The gene discussed is EEF2K; the disease is neuroblastoma.